Synergistic effect and antibiofilm activity between the antimicrobial peptide coprisin and conventional antibiotics against opportunistic bacteria

Current Microbiology

Volumn 66, Issue 1, 2013, Pages 56-60

  Hwang, In Sok ^a   Hwang, Jae Sam ^b   Hwang, Ji Hong ^a   Choi, Hyemin ^a   Lee, Eunjung ^c   Kim, Yangmee ^c   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; COPRISIN; HYDROXYL RADICAL; POLYPEPTIDE ANTIBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BIOFILM; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DRUG SYNERGISM; HYDROXYL RADICAL; INSECT PROTEINS; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS); COLEOPTERA; COPRIS;

EID: 84871623206     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-012-0239-8     Document Type: Article

References (20)

1. Archer GL (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26:1179-1181
2. Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M (2011) Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem 18:256-279
3. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250
4. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996-1006
5. Costerton JW, Irvin RT, Cheng KJ (1981) The bacterial glycocalyx in nature and disease. Ann Rev Microbiol 35:299-324
6. Eliopoulos GM, Moellering RC (1991) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine, 3rd edn. The Williams &Wilkins Co., Maryland, pp 432-492
7. Gomes F, Teixeira P, Cerca N, Azeredo J, Oliveira R (2011) Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Curr Microbiol 63:354-359
8. Hwang JS, Lee J, Kim YJ, Bang HS, Yun EY, Kim SR, Suh HJ, Kang BR, Nam SH, Jeon JP, Kim I, Lee DG (2009) Isolation and characterization of a defensin-like peptide (coprisin) from the dung beetle, Copris tripartitus. Int J Pept 2009:1-5
9. Kim JS, Heo P, Yang TJ, Lee KS, Jin YS, Kim SK, Shin D, Kweon DH (2011) Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem Biophys Res Commun 413:105-110
10. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810
11. Lee J, Hwang JS, Hwang I, Cho J, Lee E, Kim Y, Lee DG (2012) Coprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms. Free Radic Biol Med 52:2302-2311
12. Mazumdar K, Dutta NK, Kumar KA, Dastidar SG (2005) In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains. Biol Pharm Bull 28:713-717
13. Merrifield B (1986) Solid phase synthesis. Science 232:341-347
14. Monroe D (2007) Looking for chinks in the armor of bacterial biofilms. PLoS Biol 5:e307
15. Price M, Reiners JJ, Santiago AM, Kessel D (2009) Monitoring singlet oxygen and hydroxyl radical formation with fluorescent probes during photodynamic therapy. Photochem Photobiol 85:1177-1181
16. Sheppard R (2003) The fluorenylmethoxycarbonyl group in solid phase synthesis. J Pept Sci 9:545-552
17. Wayne PA (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clinical and Laboratory Standards Institute M7-A6
18. Wayne PA (2005) Performance standards for antimicrobial susceptibility testing, fifteenth informational supplement. Clinical and Laboratory Standards Institute MS100-S15
19. Wei GX, Campagna AN, Bobek LA (2006) Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57:1100-1109
20. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55